← Leaderboards
Reza Dana
Schepens Eye Research Institute
$38,921,361
Attributed
$39,701,319
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,701,319 · 9
By mechanism
R01$24,275,161 · 3
K12$11,662,830 · 1
R21$1,609,356 · 3
R61$1,559,917 · 1
K24$594,055 · 1
Top collaborators
- Yihe Chen1 shared
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Ula V. Jurkunas$9,535,499
- Varun Kumar$952,488
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineMolecularMediatingGrantImmuneCorneaBaseImmunityInflammatoryCellsRegulatory T-LymphocytePhenotypeInflammationResearch DesignAntigen-Presenting CellsIn VivoAreaResponseInsightLeadIn VitroOcular SurfaceLaboratoriesFunctional Disorder
Grant awards (80)
Mechanisms of Sensitization in High Risk Corneal Grafts$671,244
R01 · FY2025 · EY · contact PI
Immunopathogenic Mechanisms of Dry Eye Disease$587,562
R01 · FY2025 · EY · contact PI
The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival$418,625
R01 · FY2025 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$3,990
K12 · FY2025 · EY · contact PI
Topical Neurokinin-1 Receptor Antagonist as an Effective Non-addictive Analgesic for Ocular Pain$1,559,917
R61 · FY2024 · NS · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$671,244
R01 · FY2024 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$545,160
K12 · FY2024 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$492,500
R01 · FY2024 · EY · contact PI
The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival$492,500
R01 · FY2024 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$671,244
R01 · FY2023 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$545,160
K12 · FY2023 · EY · contact PI
The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival$492,500
R01 · FY2023 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$492,500
R01 · FY2023 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$651,107
R01 · FY2022 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$545,160
K12 · FY2022 · EY · contact PI
The Impact of Donor Diabetes on Corneal Immune Cells and Graft Survival$492,500
R01 · FY2022 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$477,725
R01 · FY2022 · EY · contact PI
Therapeutic Function of alpha-Melanocyte Stimulating Hormone (α-MSH) in Acute Injury and Chronic Degeneration of Corneal Endothelium$238,863
R21 · FY2022 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$671,244
R01 · FY2021 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$545,160
K12 · FY2021 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$477,725
R01 · FY2021 · EY · contact PI
Therapeutic Function of alpha-Melanocyte Stimulating Hormone (α-MSH) in Acute Injury and Chronic Degeneration of Corneal Endothelium$295,500
R21 · FY2021 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$124,841
K12 · FY2021 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$556,228
R01 · FY2020 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$513,261
K12 · FY2020 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$492,500
R01 · FY2020 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$124,896
R01 · FY2020 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$735,303
K12 · FY2019 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$556,228
R01 · FY2019 · EY · contact PI
Efficacy of the Neuropeptide Alpha-Melanocyte Stimulating Hormone (α-MSH) in Promoting Survival of Corneal Endothelial Cells in Eye Banking and Transplantation$295,500
R21 · FY2019 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$12,185
R01 · FY2019 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$758,934
K12 · FY2018 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$556,228
R01 · FY2018 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$492,500
R01 · FY2018 · EY · contact PI
Efficacy of the Neuropeptide Alpha-Melanocyte Stimulating Hormone (α-MSH) in Promoting Survival of Corneal Endothelial Cells in Eye Banking and Transplantation$246,250
R21 · FY2018 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$556,228
R01 · FY2017 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$509,983
K12 · FY2017 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$492,500
R01 · FY2017 · EY · contact PI
Mechanisms of sensitization in High Risk Corneal Grafts$688,436
R01 · FY2016 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$632,307
K12 · FY2016 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$492,500
R01 · FY2016 · EY · contact PI
Mechanisms of sensitization in High Risk Corneal Grafts$674,667
R01 · FY2015 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$630,563
K12 · FY2015 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$482,650
R01 · FY2015 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$1,099,416
K12 · FY2014 · EY · contact PI
Mechanisms of sensitization in High Risk Corneal Grafts$688,436
R01 · FY2014 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$492,500
R01 · FY2014 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$611,302
R01 · FY2013 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$595,830
K12 · FY2013 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$398,088
R01 · FY2013 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$643,475
R01 · FY2012 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$419,040
R01 · FY2012 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$222,102
K12 · FY2012 · EY · contact PI
New Strategies for Modulation of Corneal and Ocular Surface Inflammation$118,811
K24 · FY2012 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$643,475
R01 · FY2011 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$419,040
R01 · FY2011 · EY · contact PI
New Strategies for Modulation of Corneal and Ocular Surface Inflammation$118,811
K24 · FY2011 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$671,270
R01 · FY2010 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$661,292
K12 · FY2010 · EY · contact PI
Immunopathogenic mechanisms of dry eye disease$438,375
R01 · FY2010 · EY · contact PI
New Strategies for Modulation of Corneal and Ocular Surface Inflammation$118,811
K24 · FY2010 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$620,971
R01 · FY2009 · EY · contact PI
New Strategies for Modulation of Corneal and Ocular Surface Inflammation$118,811
K24 · FY2009 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$590,164
R01 · FY2008 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$583,096
K12 · FY2008 · EY · contact PI
New Strategies for Modulation of Corneal and Ocular Surface Inflammation$118,811
K24 · FY2008 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$705,238
K12 · FY2007 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$607,233
R01 · FY2007 · EY · contact PI
Harvard-Vision Clinical Scientist Development Program$746,051
K12 · FY2006 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$592,872
R01 · FY2006 · EY · contact PI
Promoting Corneal Graft by Anti-Apoptotic Genes$239,243
R21 · FY2006 · EY · contact PI
Mechanisms of Sensitization in High Risk Corneal Grafts$589,454
R01 · FY2005 · EY
Harvard-Vision Clinical Scientist Development Program$570,020
K12 · FY2005 · EY
Promoting Corneal Graft by Anti-Apoptotic Genes$294,000
R21 · FY2005 · EY
MECHANISMS OF SENSITIZATION IN HIGH-RISK CORNEAL GRAFTS$392,000
R01 · FY2004 · EY
Harvard-Vision Clinical Scientist Development Program$389,963
K12 · FY2004 · EY
MECHANISMS OF SENSITIZATION IN HIGH-RISK CORNEAL GRAFTS$372,000
R01 · FY2003 · EY
MECHANISMS OF SENSITIZATION IN HIGH-RISK CORNEAL GRAFTS$391,500
R01 · FY2002 · EY
MECHANISMS OF SENSITIZATION IN HIGH-RISK CORNEAL GRAFTS$391,500
R01 · FY2001 · EY
MECHANISMS OF SENSITIZATION IN HIGH-RISK CONRNEAL GRAFTS$364,500
R01 · FY2000 · EY